Manufacturer record
Wings biotech LLP 43 & 44: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Wings biotech LLP 43 & 44 (Himachal Pradesh) were declared Not of Standard Quality between June 2023 and July 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Wings biotech LLP 43 & 44 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ibuprofen and Paracetamol Tablets IP (400mg/325mg), | IPPT-1018Mfg 2025-05 · Exp 2027-04 | Test of Uniformity of weightUniformity of weight/content | RDTL, ChandigarhCDSCO lab | Jul 2025 |
| Chlorpheniramine Maleate & Codeine Phosphate Syrup ONEREX? COUGH SYRUP | ONCS 1713Mfg 2022-03 · Exp 2024-02 | Identification and Assay of Codeine phosphateAssay | RDTL GuwahatiState lab | Jun 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.